[PDF][PDF] Bevacizumab in combination with chemotherapy as first-line therapy in advanced gastric cancer: a randomized, double-blind, placebo-controlled phase III study
A Ohtsu, MA Shah, E Van Cutsem, SY Rha… - J Clin …, 2011 - researchgate.net
A Ohtsu, MA Shah, E Van Cutsem, SY Rha, A Sawaki, SR Park, HY Lim, Y Yamada, J Wu…
J Clin Oncol, 2011•researchgate.netBevacizumab in Combination With Chemotherapy As First-Line Therapy in Advanced Gastric
Cancer: A Randomized, Double-Blind, Place Page 1 Bevacizumab in Combination With
Chemotherapy As First-Line Therapy in Advanced Gastric Cancer: A Randomized, Double-Blind,
Placebo-Controlled Phase III Study Atsushi Ohtsu, Manish A. Shah, Eric Van Cutsem, Sun
Young Rha, Akira Sawaki, Sook Ryun Park, Ho Yeong Lim, Yasuhide Yamada, Jian Wu, Bernd
Langer, Michal Starnawski, and Yoon-Koo Kang Atsushi Ohtsu, National Cancer Center Hospital …
Cancer: A Randomized, Double-Blind, Place Page 1 Bevacizumab in Combination With
Chemotherapy As First-Line Therapy in Advanced Gastric Cancer: A Randomized, Double-Blind,
Placebo-Controlled Phase III Study Atsushi Ohtsu, Manish A. Shah, Eric Van Cutsem, Sun
Young Rha, Akira Sawaki, Sook Ryun Park, Ho Yeong Lim, Yasuhide Yamada, Jian Wu, Bernd
Langer, Michal Starnawski, and Yoon-Koo Kang Atsushi Ohtsu, National Cancer Center Hospital …
Purpose
The Avastin in Gastric Cancer (AVAGAST) trial was a multinational, randomized, placebo-controlled trial designed to evaluate the efficacy of adding bevacizumab to capecitabine-cisplatin in the first-line treatment of advanced gastric cancer.
researchgate.net
